• About
  • Subscribe
  • Advertise
  • Contact
Thursday, February 12, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Professor Ian Constable celebrates 50 years in ophthalmology at UWA

by Staff Writer
February 20, 2025
in Eye disease, Eye research institutions, Industry profiles, Local, Medical schools, News, Ophthalmic Careers, Ophthalmic education, Ophthalmic organisations, Ophthalmologists, Research
Reading Time: 4 mins read
A A
Professor Ian Constable. Image: UWA.

Professor Ian Constable. Image: UWA.

Share on FacebookShare on Twitter

“It seems like just yesterday,” reflects Professor Ian Constable AO, reminiscing about his arrival at The University of Western Australia as the Foundation Lions Professor of Ophthalmology in April 1975.

The university is celebrating Prof Constable’s half a century with the organisation.

In a media release it said he was possibly UWA’s longest-serving full professor, and “the internationally renowned specialist’s 50-year journey has transformed eye health research and care, not just in Western Australia, but globally”.

After graduating in medicine from the University of Sydney and working as a resident medical officer at Royal Prince Alfred Hospital, the young ophthalmologist’s path led him to Harvard in Boston, US.

He spent five years engaged in retinal research as a Fellow at the Massachusetts Eye and Ear Infirmary and later as a consultant surgeon and lecturer at Harvard University.

In 1975, he brought this wealth of experience to Perth, taking up the inaugural Lions Chair of Ophthalmology at UWA.

“I had five years of lab work at Harvard, so I was used to setting things up and I was used to talking to scientists,” Prof Constable said in the release.

This experience proved invaluable as he began building his team, recruiting promising UWA postgraduates in cell biology, physiology and polymer chemistry.

His approach was revolutionary for its time, the university said.

“From the very beginning we used our ability to see and treat patients to generate funding – we would take an eye problem and apply science to it rather than just clinical work, which was great training and a career opportunity for our young scientists,” he explains.

Professor Ian Constable with a patient at Royal Perth Hospital, 1975. Image: Ian Constable.

This philosophy led to remarkable breakthroughs, including the world’s first virus-transmitted DNA treatment in adult humans with macular degeneration – research that began in Perth and eventually led to a US$400 million listing on the New York Stock Exchange.

The journey wasn’t without its challenges, the UWA said.

As his research team expanded beyond Royal Perth Hospital’s capacity, then-Premier Sir Charles Court offered space at the old Sir Charles Gairdner Hospital.

This move in 1985 marked the beginning of what would become the Lions Eye Institute, now a world-renowned centre for eye research and clinical care.

Throughout his career, Prof Constable maintained a deep connection with UWA.

“The relationship with the university has always been fantastic because it allowed me to try everything possible through the years,” he says.

“I was helped extensively by Professor Bob Whelan in the 1970s, Robert Street in the 1980s, and then by the then-VC Alan Robson in setting up UWA’s Centre for Ophthalmology and Visual Science in the 1990s.

“We’ve been able to appoint people from outside onto the university staff and use the facilities and infrastructure; it’s been a terrific relationship.

“Both my sons attended UWA and my wife Elizabeth, who was a Member of Parliament and the Minister for Education, was a Vice-Chancellor’s Fellow for five years after she retired from politics and so our links with the university are comprehensive.”

Prof Constable’s commitment to Indigenous eye health has been “particularly significant”, culminating in the establishment of the comprehensive Lions Outback Vision service in Broome by UWA’s Professor Angus Turner.

“It’s a first-world service centre in a disadvantaged environment,” he says, describing how the program now serves communities across the Kimberley and Pilbara regions with a resident team including a dedicated pilot who flies specialists to remote areas.

Even after 50 years, his passion for innovation remains undimmed. He continues to collaborate on cutting-edge RNA therapy in Perth and collaborates internationally on glaucoma research through the Snow Family Medical Foundation and retinal disease through the Lowy Family Medical Research Institute.

Still seeing patients two days a week, he finds particular joy in working with young graduates and undergraduates.

“It’s good to be around young people – to see them grow is the best part of it all,” he says of the many scientists and clinicians he has mentored over the decades.

As he reflects on his legacy, his hopes remain focused on service. “I just hope that in WA we continue to have a first-class, international service and good research and good teaching,” he says.

More reading

Snow family donating $50m to glaucoma research at University of Sydney

Lions Eye Institute: one million reasons to celebrate 40 years of saving sight

Perth institutions appoint first chair in ophthalmic big data

Related Posts

The study looked at the impact of bacteria found in the eye. Image: Sokie/stock.adobe.com.

Study: Bacterium in retina linked to Alzheimer’s disease, cognitive decline

by Staff Writer
February 12, 2026

Researchers at Cedars-Sinai Medical Center in the US have established a link between bacterium in the retina and cognitive decline...

The system integrates a built-in PC and tiltable touch-screen display in a compact footprint. Image: BOC Instruments

BOC Instruments introduces automated AutoFusion OCT device

by Staff Writer
February 11, 2026

BOC Instruments has announced the release of a new Optovue optical coherence tomography (OCT) system, the AutoFusion, which combines OCT...

A Belgian firm has taken a big stake in Rayner. Image: Rayner.

Firm spending $840 million for big stake in Rayner

by Rob Mitchell
February 11, 2026

Belgian investment holding company Groupe Bruxelles Lambert (GBL) is investing €500 million (AU$840  million) in British ophthalmic manufacturer Rayner. An...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited